Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.16 HKD | -0.81% | +6.39% | -8.47% |
Jun. 03 | Simcere Pharmaceutical’s Cancer Drug Shows Positive Results | MT |
Jun. 03 | Simcere Pharma Presents Results of Phase 3 Trial for Anti-Cancer Injection at US Oncology Society Meeting | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.47% | 2.03B | |
+18.09% | 41.07B | |
+24.16% | 22.65B | |
+15.71% | 15.02B | |
+20.11% | 14.14B | |
+52.15% | 12.09B | |
-10.97% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+15.28% | 5.59B |
- Stock Market
- Equities
- 2096 Stock
- News Simcere Pharmaceutical Group Limited
- Simcere Pharmaceutical Group's Cancer Drug NDA Accepted by Chinese Regulator